Evaluation of two new assays for tumor-associated antigens, CASA and OSA, found in the serum of patients with epithelial ovarian carcinoma—Comparison with CA125
- 1 May 1990
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 37 (2), 165-171
- https://doi.org/10.1016/0090-8258(90)90328-i
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Expression of Multiple Tumour Markers in Serum from Patients with Ovarian Carcinoma and Healthy WomenAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1989
- Measurement of the ovarian cancer-associated antigen CA 125 prior to second look operationEuropean Journal of Cancer and Clinical Oncology, 1988
- Predictive value of serial CA 125 antigen levels in ovarian cancer evaluated by second-look laparotomyEuropean Journal of Cancer and Clinical Oncology, 1987
- CA125 Serum Levels and Secondary Laparotomy in Epithelial Ovarian TumoursAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1987
- Circulating tumour-associated antigen detected by the monoclonal antibody HMFG2 in human epithelial ovarian cancerInternational Journal of Cancer, 1987
- Biochemical characterization of the monoclonal antibody‐defined ovarian carcinoma‐associated antigen SGAInternational Journal of Cancer, 1986
- CA 125 Serum Levels Correlated With Second-Look Operations Among Ovarian Cancer PatientsObstetrics & Gynecology, 1986
- Serum CA 125 in Ovarian Pathology and Its Variation in Ovarian Carcinoma after Integrated TherapyGynecologic and Obstetric Investigation, 1986
- The sebaceous gland antigen defined by the OM-1 monoclonal antibody is expressed at high density on the surface of ovarian carcinoma cellsEuropean Journal of Cancer and Clinical Oncology, 1985
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983